ALIGNMENT HEALTHCARE INC (ALHC) Forecast, Price Target & Analyst Ratings

NASDAQ:ALHCUS01625V1044

Current stock price

17.42 USD
-0.09 (-0.51%)
At close:
17.7 USD
+0.28 (+1.61%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALIGNMENT HEALTHCARE INC (ALHC).

Forecast Snapshot

Consensus Price Target

Price Target
$25.59
+ 46.92% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$0.01
Revenue Estimate
1.242B

ChartMill Buy Consensus

Rating
85.26%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$25.59
Upside
+ 46.92%
From current price of $17.42 to mean target of $25.59, Based on 19 analyst forecasts
Low
$18.18
Median
$25.50
High
$31.50

Price Target Revisions

1 Month
0.70%
3 Months
18.31%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for ALHC. The average price target is 25.59 USD. This implies a price increase of 46.92% is expected in the next year compared to the current price of 17.42.
The average price target has been revised upward by 18.31% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

ALHC Current Analyst RatingALHC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ALHC Historical Analyst RatingsALHC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.26%
ALHC was analyzed by 19 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ALHC.
In the previous month the buy percentage consensus was at a similar level.
ALHC was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-05JP MorganMaintains Overweight -> Overweight
2026-01-16TD CowenMaintains Buy -> Buy
2026-01-14UBSMaintains Neutral -> Neutral
2026-01-06Piper SandlerMaintains Overweight -> Overweight
2025-12-17JP MorganMaintains Overweight -> Overweight
2025-11-24JP MorganUpgrade Neutral -> Overweight
2025-11-05JP MorganMaintains Neutral -> Neutral
2025-11-03BarclaysMaintains Equal-Weight -> Equal-Weight
2025-10-31UBSMaintains Neutral -> Neutral
2025-10-14Goldman SachsInitiate Buy
2025-08-25KeybancUpgrade Sector Weight -> Overweight
2025-07-31BarclaysUpgrade Underweight -> Equal-Weight
2025-05-02UBSMaintains Neutral -> Neutral
2025-04-15BairdMaintains Outperform -> Outperform
2025-04-08StifelMaintains Buy -> Buy
2025-03-06JP MorganMaintains Neutral -> Neutral
2025-03-04B of A SecuritiesMaintains Buy -> Buy
2025-03-04Piper SandlerMaintains Overweight -> Overweight
2025-02-28StifelMaintains Buy -> Buy
2025-02-28BarclaysMaintains Underweight -> Underweight
2025-02-24Stephens & Co.Reiterate Overweight -> Overweight
2025-01-14StifelMaintains Buy -> Buy
2025-01-02Stephens & Co.Reiterate Overweight -> Overweight
2024-12-03Stephens & Co.Upgrade Equal-Weight -> Overweight
2024-10-31TD CowenMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$0.01
Revenue Estimate
1.242B
Revenue Q2Q
33.99%
EPS Q2Q
114.28%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-0.96%
Revenue (3 Months)
0.24%
EPS (1 Month)
-36.99%
EPS (3 Months)
-36.99%

Next Earnings Summary

ALHC is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.01 USD and the consensus revenue estimate is 1.24B USD.
The next earnings revenue estimate has been revised upward by 0.24% in the past 3 months.

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ALHC revenue by date.ALHC revenue by date.
1.824B
27.15%
2.704B
48.25%
3.949B
46.06%
5.294B
34.07%
6.668B
25.95%
8.283B
24.22%
10.736B
29.61%
13.5B
25.75%
11.841B
-12.29%
EBITDA
YoY % growth
ALHC ebitda by date.ALHC ebitda by date.
-106.149M
4.46%
-73.848M
30.43%
45.234M
161.25%
153.97M
240.39%
222.18M
44.30%
300.73M
35.35%
434.52M
44.49%
559.27M
28.71%
N/A
EBIT
YoY % growth
ALHC ebit by date.ALHC ebit by date.
-127.817M
0.61%
-100.91M
21.05%
14.752M
114.62%
118.17M
701.04%
182.5M
54.44%
210.04M
15.09%
N/AN/AN/A
Operating Margin
ALHC operating margin by date.ALHC operating margin by date.
-7.01%-3.73%0.37%2.23%2.74%2.54%N/AN/AN/A
EPS
YoY % growth
ALHC eps by date.ALHC eps by date.
-0.78
4.88%
-0.67
14.10%
-0.01
98.51%
0.45
4,562.50%
0.38
-13.83%
0.73
89.09%
1.45
99.20%
N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
0.01
114.28%
0.12
75.88%
0.05
173.36%
-0.06
-10.83%
0.07
911.86%
0.21
66.53%
0.14
151.55%
-0.03
39.57%
0.14
90.60%
0.33
59.20%
0.27
96.54%
-0.01
69.54%
Revenue
Q2Q % growth
1.242B
33.99%
1.354B
33.36%
1.347B
35.55%
1.347B
33.00%
1.573B
26.65%
1.696B
25.26%
1.688B
25.32%
1.692B
25.61%
2.015B
28.10%
2.194B
29.36%
2.123B
25.77%
2.129B
25.83%
EBITDA
Q2Q % growth
32.701M
1,363.79%
58.239M
55.67%
44.184M
45.68%
19.3M
-4.45%
50.698M
55.04%
75.558M
29.74%
63.042M
42.68%
28.31M
46.68%
66.116M
30.41%
102.5M
35.66%
110.87M
75.87%
27.897M
-1.46%
EBIT
Q2Q % growth
15.572M
388.74%
39.977M
75.74%
26.804M
248.96%
3.948M
138.39%
20.244M
30.00%
48.142M
20.42%
30.298M
13.04%
-374.595K
-109.49%
56.814M
180.65%
93.789M
94.82%
101.2M
234.02%
17.891M
4,876.09%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALHC Yearly Revenue VS EstimatesALHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
ALHC Yearly EPS VS EstimatesALHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
321.18%
EPS Next 5 Year
248.11%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
27.27%
Revenue Next 5 Year
27.43%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
155.45%
EBIT Next 5 Year
98.73%

ALIGNMENT HEALTHCARE INC / ALHC Forecast FAQ

Can you provide the average price target for ALIGNMENT HEALTHCARE INC stock?

19 analysts have analysed ALHC and the average price target is 25.59 USD. This implies a price increase of 46.92% is expected in the next year compared to the current price of 17.42.

Can you provide the upcoming earnings date for ALIGNMENT HEALTHCARE INC?

ALIGNMENT HEALTHCARE INC (ALHC) will report earnings on 2026-04-29, after the market close.

What are the consensus estimates for ALHC stock next earnings?

The consensus EPS estimate for the next earnings of ALIGNMENT HEALTHCARE INC (ALHC) is 0.01 USD and the consensus revenue estimate is 1.24B USD.

What is the consensus rating for ALIGNMENT HEALTHCARE INC (ALHC) stock?

The consensus rating for ALIGNMENT HEALTHCARE INC (ALHC) is 85.2632 / 100 . This indicates that analysts generally have a positive outlook on the stock.